PMC9134426_01
Timeline of case 1.. BCP-ALL: B-cell precursor acute lymphoblastic leukaemia; BM: bone marrow;
CAR: chimeric antigen receptor; d: days; GvHD: graft-versus-host disease;
HSCT: hematopoietic stem cell transplantation; MRD: minimal residual
disease; PB: peripheral blood; PBSC: peripheral blood stem cells; PCR:
polymerase chain reaction; TBI: total body irradiation; VP-16: etoposide; w:
weeks; and y: years.
10.1177_20406207221099468-fig1.jpg
PMC9134426_02_10.1177_20406207221099468-fig1.jpg
fig1-20406207221099468
PMC9134426_02
Timeline of case 1.. BCP-ALL: B-cell precursor acute lymphoblastic leukaemia; BM: bone marrow;
CAR: chimeric antigen receptor; d: days; GvHD: graft-versus-host disease;
HSCT: hematopoietic stem cell transplantation; MRD: minimal residual
disease; PB: peripheral blood; PBSC: peripheral blood stem cells; PCR:
polymerase chain reaction; TBI: total body irradiation; VP-16: etoposide; w:
weeks; and y: years.
10.1177_20406207221099468-fig1.jpg
PMC9134426_02_10.1177_20406207221099468-fig1.jpg
fig1-20406207221099468
Timeline of case 2.. BCP-ALL: B-cell precursor acute lymphoblastic leukaemia; BM: bone marrow;
CAR: chimeric antigen receptor; CRS: cytokine release syndrome; d: days;
GvHD: graft-versus-host disease; HSCT: hematopoietic stem cell
transplantation; MRD: minimal residual disease; PB: peripheral blood; PBSC:
peripheral blood stem cells; PCR: polymerase chain reaction; TBI: total body
irradiation; VP-16: etoposide; w: weeks; y: years.
10.1177_20406207221099468-fig2.jpg
PMC9134426_02_10.1177_20406207221099468-fig2.jpg
fig2-20406207221099468